VCI Wealth Management LLC Makes New $996,000 Investment in Zoetis Inc. $ZTS

VCI Wealth Management LLC acquired a new stake in shares of Zoetis Inc. (NYSE:ZTS) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,804 shares of the company’s stock, valued at approximately $996,000.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Zoetis by 0.8% during the 2nd quarter. Vanguard Group Inc. now owns 41,886,987 shares of the company’s stock worth $6,532,276,000 after purchasing an additional 330,823 shares during the last quarter. Geode Capital Management LLC increased its stake in Zoetis by 0.9% during the 2nd quarter. Geode Capital Management LLC now owns 11,081,301 shares of the company’s stock worth $1,721,356,000 after buying an additional 95,294 shares in the last quarter. Norges Bank acquired a new position in shares of Zoetis during the second quarter valued at approximately $809,491,000. Brown Advisory Inc. raised its holdings in shares of Zoetis by 5.7% during the second quarter. Brown Advisory Inc. now owns 4,659,371 shares of the company’s stock valued at $726,629,000 after acquiring an additional 250,829 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Zoetis by 4.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,252,697 shares of the company’s stock worth $700,207,000 after acquiring an additional 174,119 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

ZTS has been the subject of several recent research reports. KeyCorp initiated coverage on Zoetis in a research note on Thursday, November 20th. They issued a “sector weight” rating for the company. JPMorgan Chase & Co. dropped their target price on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Bank of America cut shares of Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 target price for the company. in a research report on Monday, December 15th. BTIG Research restated a “buy” rating and set a $160.00 price target on shares of Zoetis in a research report on Wednesday, December 3rd. Finally, Barclays assumed coverage on shares of Zoetis in a research note on Monday, December 8th. They set an “equal weight” rating and a $136.00 price objective for the company. Six analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $160.18.

Zoetis Stock Up 1.6%

Shares of ZTS opened at $125.50 on Friday. Zoetis Inc. has a 52-week low of $115.25 and a 52-week high of $177.40. The company has a quick ratio of 2.28, a current ratio of 3.64 and a debt-to-equity ratio of 1.31. The stock has a fifty day simple moving average of $127.41 and a two-hundred day simple moving average of $143.41. The company has a market capitalization of $55.31 billion, a PE ratio of 21.13, a price-to-earnings-growth ratio of 2.73 and a beta of 0.97.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter in the previous year, the company posted $1.58 EPS. The company’s revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be issued a dividend of $0.53 per share. The ex-dividend date is Tuesday, January 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.7%. This is an increase from Zoetis’s previous quarterly dividend of $0.50. Zoetis’s payout ratio is 33.67%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.